ArticleJournal of extracellular biology2026
HIV Tat-Stimulated Microglial Extracellular Vesicles Are Enriched for Ferroptosis Mediators: Role of Dysregulated Autophagy.
Article in Journal of extracellular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) serve as conduits for intercellular communication, under both physiological and pathological contexts. During disease pathogenesis, microglia-derived EVs (MEVs) play a key role in transferring pathological cargo to the recipient cells, thereby modulating their phenotype and function. The current study was aimed to explore how HIV Transactivator of transcription (Tat) protein-mediated dysregulated autophagy/ferritinophagy contributes to the expression and release of ferroptotic mediators in Tat-activated MEVs. Exposure of microglial BV2 cells to HIV Tat for 48 h resulted in significantly increased expression of the ferroptosis mediators-FTH1 and ACSL4 in Tat-MEVs. Reciprocally, pretreatment of microglia with the ferroptosis inhibitors abrogated the expression and release of these mediators in both microglial cells as well as in Tat-MEVs, without affecting the overall MEV release. Furthermore, inhibition of autophagic flux with bafilomycin A1 resulted in potentiation of HIV Tat-mediated expression and release of ferroptosis mediators in Tat-MEVs. In contrast, treatment of cells with the autophagy inducer- rapamycin, attenuated these effects. Exposure of BV2 cells to HIV Tat also resulted in increased expression of the ferritinophagy adaptor protein NCOA4, an effect mitigated by both ferroptosis inhibitors and rapamycin. These findings were also validated in brain lysates as well as brain-derived MEVs isolated from HIV Transgenic rats. Collectively, this study highlights the role of dysregulated autophagy in modulating both HIV Tat-induced ferroptosis and the release of ferroptosis cargo in MEVs. These findings advance our understanding of the molecular mechanism(s) driving HIV-associated neuropathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.